Botulinum toxin in patients with multiple sclerosis
✍ Scribed by Christian Kabus; Martin Hecht; Gudrun Japp; Wolfgang H. Jost; Dieter Pöhlau; Sebastian Stuckrad-Barre; Martin Winterholler
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 173 KB
- Volume
- 253
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Botulinum toxin type A (btx A) injections are the most effective treatment for most patients with focal dystonia. Some patients who improve after btx A injections and later lose response have serologic evidence of antibodies to btx A with the mouse neutralization assay (seropositive pat
## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after